Syngenta closes acquisition of Monsanto’s sunflower seeds activities

Basel, Switzerland

* Purchase further strengthens leading sunflower business
* Remedies proposal accepted by European Commission


Syngenta announced today that it has closed the acquisition of Monsanto’s global hybrid sunflower seeds activities. This follows merger filing procedures with the European Commission and Syngenta’s commitment to divest certain physical assets, intellectual property rights and contracts. Details of the remedies proposal will not be disclosed.

Syngenta announced on 6 August, 2009, the signing of an agreement to acquire from Monsanto its global hybrid sunflower seeds activities for a consideration of $160 million, on a cash and debt-free basis. The asset deal includes germplasm and related IP rights, all sunflower breeding activities, certain activities in field production as well as the global distribution rights for all Monsanto sunflower hybrids. The acquisition further strengthens Syngenta’s leading sunflower business.

About Syngenta

Syngenta is one of the world’s leading companies with more than 25,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com or www.growmorefromless.com.

Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta’s publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.